Double delight in latest VMRAF funding
By Rob Clancy, staff writer
Two Hudson Institute research projects are among 14 statewide to receive funding in the latest round of grants from the Victorian Medical Research Acceleration Fund (VMRAF).
Established by the Victorian Government in 2017, the VMRAF provides funding support to accelerate health and medical research, fast-tracking innovative projects from the laboratory to real-world impact.
Professor Michelle Tate and Professor Jun Yang will each receive Tier 1 funding of approximately $100,000 over the next two years.
Awarded through a highly competitive process, these grants back innovative early-stage discoveries with strong translational potential, helping researchers take critical steps towards delivering tangible benefits for patients and the community.
Development of Blood-Based Neutrophil Biomarkers for Early Detection of Silicosis: An Innovative Early-Stage Research Approach
Professor Michelle Tate
Approximately $100,000 over the next two years.
Advancing Precision Diagnosis and Personalised Treatment of Primary Aldosteronism Through Genetic Testing
Professor Jun Yang
Approximately $100,000 over the next two years.
This research was supported by | Victorian Medical Research Acceleration Fund (VMRAF)
About Hudson Institute
Hudson Institute’ s research programs deliver in three areas of medical need – inflammation, cancer, women’s and newborn health. More
Hudson News
Get the inside view on discoveries and patient stories
“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”